Kenneth Allen Myszkowski

Companies

• Arrowhead PharmaceuticalsChief financial officer Apr 15, 2010 to Jan 7, 2025¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APArrowhead Pharmaceuticals ARWR455,433 shares²$25.8M at $56.73Jan 7, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 7, 2025Sold 10,000 shares at $19.69 of Arrowhead Pharmaceuticals²
• Jan 7, 2025Sold 8,000 shares at $19.70 of Arrowhead Pharmaceuticals²
• Jan 6, 2025Sold 9,402 shares at $20.10 of Arrowhead Pharmaceuticals²
• Jan 6, 2025Sold 17,765 shares at $19.68 of Arrowhead Pharmaceuticals²
• Jan 4, 2025Granted 100,000 shares of Arrowhead Pharmaceuticals²
• Mar 6, 2024Sold 40,000 shares at $35.19 of Arrowhead Pharmaceuticals³
• Jan 5, 2024Sold 8,904 shares at $35.65 of Arrowhead Pharmaceuticals⁴
• Jan 5, 2024Sold 5,800 shares at $34.97 of Arrowhead Pharmaceuticals⁴
• Jan 5, 2024Sold 1,400 shares at $34.04 of Arrowhead Pharmaceuticals⁴
• Jan 4, 2024Granted 75,000 shares of Arrowhead Pharmaceuticals⁴
• Jun 27, 2023Sold 15,000 shares at $36.20 of Arrowhead Pharmaceuticals⁵
• Jan 4, 2023Granted 60,000 shares of Arrowhead Pharmaceuticals⁶
• Dec 29, 2022Sold 30,625 shares at $40.00 of Arrowhead Pharmaceuticals⁷
• Jun 15, 2022Gift 96,676 shares of Arrowhead Pharmaceuticals⁸
• Jan 5, 2022Sold 3,786 shares at $63.95 of Arrowhead Pharmaceuticals⁹
• Jan 5, 2022Sold 3,778 shares at $63.17 of Arrowhead Pharmaceuticals⁹
• Jan 5, 2022Sold 16,528 shares at $62.00 of Arrowhead Pharmaceuticals⁹
• Jan 5, 2022Sold 15,908 shares at $60.50 of Arrowhead Pharmaceuticals⁹
• Jan 1, 2022Granted 60,000 shares of Arrowhead Pharmaceuticals¹⁰